- First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial. Alexander, J.H., Yang, H., Becker, R.C., Kodama, K., Goodman, S., Dyke, C.K., Kleiman, N.S., Hochman, J.S., Berger, P.B., Cohen, E.A., Lincoff, A.M., Burton, J.R., Bovill, E.G., Kawai, C., Armstrong, P.W., Harrington, R.A. J. Thromb. Haemost. (2005)